April 27th-28th, 2026
London, United Kingdom
The 24th Orphan Drugs & Rare Diseases Global Congress 2026 Europe brings together professionals from across pharmaceutical development, rare disease research, clinical operations, patient advocacy and regulatory affairs to address key challenges and opportunities in orphan drug development and rare disease care. Over two days, the congress explores innovation, access, collaboration and strategic approaches shaping the future of orphan medicines, including clinical development, funding, market access and patient engagement in rare disease communities.
mdgroup team attending – make sure to say hi!
